Lexology June 5, 2024
DLA Piper

Welcome to FDA Regulatory News and Trends, designed to help you identify significant legal developments and navigate the evolving business, legal, and regulatory world.

CDRH finalizes guidance addressing device remanufacturing and servicing.

  • On May 9, 2024, the FDA Center for Devices and Radiological Health (CDRH) released a guidance document entitled, “Remanufacturing of Medical Devices.” This guidance aims to distinguish the types of activities that qualify as servicing rather than remanufacturing (which involves additional regulatory responsibilities).
  • FDA defines remanufacture as follows: “Process, condition, renovate, repackage, restore, or any other act done to a finished device that significantly changes the finished device’s performance or safety specifications, or intended use.” Since these remanufacturing activities significantly change the device’s performance or safety specifications,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: FDA, Govt Agencies
Related Articles:
FDA warns GLP-1 compounder over safety rules
GLP-1 drug approvals: A breakdown
Rethinking FDA’s Accelerated Approval Pathway: New Draft Guidances and Implications for Drug Companies
FDA approves Novo Nordisk's Ozempic to treat chronic kidney disease in those with diabetes, expanding its use
Certainty vs. speed: How do patients feel about the tradeoff for new cancer drugs?

Share This Article